For research teamsHelp me find a study
Back to all studies
CompletedNCT00228540

Modafinil for ADHD

This study is completed in the United States. It is testing modafinil for ADHD.

ADHDDrugFrom 6 Years to 17 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Modafinil may be useful for adolescents experiencing ADHD.

What would participation involve?

Participants may receive Modafinil, attend study visits with the research team. The registry lists locations in the United States.

Who is it mainly for?

This study appears to be mainly for adolescents with ADHD. Because it involves minors, a parent or guardian may need to be involved.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is a comparison group, how many visits or travel steps are needed, what role parents or guardians have in the process.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateSeptember 2005
Recruitment status
Completed
Enrollment listed in the registry
Not clearly listed
Sponsor
Cephalon
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 6 Years to 17 Years
Official registry ID
NCT00228540
Official title
An 8 Week, Open-Label Study to Characterize the Response to Modafinil (85 mg Film Coated Tablet) Treatment at Dosages Up to 425 mg/Day in Children and Adolescents With Attention Deficit/Hyperactivity Disorder (ADHD) (With an Open Ended Extension Period)

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT00228540. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

United States · 39 sites
  • Melmed Center
    Scottsdale, Arizona
    Site status: Not listed — confirm with the team
  • UCI Child Development Center
    Irvine, California
    Site status: Not listed — confirm with the team
  • Pharmacology Research Institut
    Northridge, California
    Site status: Not listed — confirm with the team
  • Pacific Sleep Medicine Service
    San Diego, California
    Site status: Not listed — confirm with the team
  • Sarkis Clinical Trials
    Gainesville, Florida
    Site status: Not listed — confirm with the team
  • Clinical Neuroscience Solution
    Jacksonville, Florida
    Site status: Not listed — confirm with the team
  • Clinical Neurosciences
    Orlando, Florida
    Site status: Not listed — confirm with the team
  • Laszlo J. Mate, MD, PA
    West Palm Beach, Florida
    Site status: Not listed — confirm with the team
  • Northwest Behavioral Research
    Marietta, Georgia
    Site status: Not listed — confirm with the team
  • Pediatrics and Adolescent
    Woodstock, Georgia
    Site status: Not listed — confirm with the team
  • Loyola University Medical Center Department of Psychiatry
    Maywood, Illinois
    Site status: Not listed — confirm with the team
  • HALP Clinic and ADHD Research
    Northbrook, Illinois
    Site status: Not listed — confirm with the team
  • Cientifica, Inc.
    Wichita, Kansas
    Site status: Not listed — confirm with the team
  • Michael J. Rieser, MD
    Lexington, Kentucky
    Site status: Not listed — confirm with the team
  • Pedia Research, LLC
    Owensboro, Kentucky
    Site status: Not listed — confirm with the team
  • Louisiana Research Associates
    New Orleans, Louisiana
    Site status: Not listed — confirm with the team
  • Psycopharmacology Research - LSU Health Science Center
    Shreveport, Louisiana
    Site status: Not listed — confirm with the team
  • Massachusetts General Hospital
    Cambridge, Massachusetts
    Site status: Not listed — confirm with the team
  • Odyssey Research
    Dearborn, Michigan
    Site status: Not listed — confirm with the team
  • Hurley Medical Center
    Flint, Michigan
    Site status: Not listed — confirm with the team
  • ProMed HealthCare
    Kalamazoo, Michigan
    Site status: Not listed — confirm with the team
  • Regions Hospital
    Saint Paul, Minnesota
    Site status: Not listed — confirm with the team
  • Odyssey Research
    McCook, Nebraska
    Site status: Not listed — confirm with the team
  • University of Nebraska
    Omaha, Nebraska
    Site status: Not listed — confirm with the team
  • Bancroft Clinical Research
    Cherry Hill, New Jersey
    Site status: Not listed — confirm with the team
  • Hunterdon Pediatric Associates
    Flemington, New Jersey
    Site status: Not listed — confirm with the team
  • Odyssey Research
    Bismarck, North Dakota
    Site status: Not listed — confirm with the team
  • Prairie at Saint John's
    Fargo, North Dakota
    Site status: Not listed — confirm with the team
  • Odyssey Research
    Minot, North Dakota
    Site status: Not listed — confirm with the team
  • Cincinnati Children's Hospital
    Cincinnati, Ohio
    Site status: Not listed — confirm with the team
  • OCCI, Inc Salem
    Salem, Oregon
    Site status: Not listed — confirm with the team
  • Medical University of SC
    Charleston, South Carolina
    Site status: Not listed — confirm with the team
  • UT Medical Group
    Memphis, Tennessee
    Site status: Not listed — confirm with the team
  • Clinical Neuroscience Solution
    Memphis, Tennessee
    Site status: Not listed — confirm with the team
  • Claghorn-Lesem Research
    Bellaire, Texas
    Site status: Not listed — confirm with the team
  • The Clinical Study Ceneter
    Burlington, Vermont
    Site status: Not listed — confirm with the team
  • Dominion Clinical Research
    Midlothian, Virginia
    Site status: Not listed — confirm with the team
  • Advanced Pediatrics
    Vienna, Virginia
    Site status: Not listed — confirm with the team
  • Eastside Therapeutic Resource
    Kirkland, Washington
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with adhd. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving Modafinil. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.

Who might this study be for?

This study may concern people with adhd; age range: From 6 Years to 17 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Cephalon, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.